Sladowski D, Liberek I, Lipski K, Ozga T, Olkowska-Truchanowicz J, Szaflik J
Department of Transplantology and Central Tissue Bank, Center of Biostructure Research, Medical University of Warsaw, ul. Chałubińskiego 5, 02-004 Warsaw, Poland.
Toxicol In Vitro. 2005 Oct;19(7):875-8. doi: 10.1016/j.tiv.2005.06.028. Epub 2005 Aug 2.
One of the main goals for toxicologists working on the development of in vitro tests is to replace the animal-based eye irritation test. Inflammation is one of the mechanisms which have not been covered sufficiently by the existing in vitro ocular irritancy test systems. As there are major species differences between the human and rabbit eye inflammation mechanisms, the most relevant test system is the human eye itself. The current study focused on an evaluation of the practical availability of human corneal epithelial cells for routine eye irritancy testing. Human corneal epithelium cell cultures were used to assess the effects of lipopolysaccharide on IL-1 beta release. The findings indicated that cytokine release can be augmented by the presence of the complement system, which is normally found in tears. However, the corneal cells were found to be highly resistant to the complement system, which can be attributed to the very high expression of CD59, a powerful complement regulatory protein found in the corneal epithelium. It is estimated that discarded corneas from tissue banks could provide enough material for routine testing by this method.
致力于开发体外试验的毒理学家的主要目标之一是取代基于动物的眼刺激试验。炎症是现有体外眼刺激试验系统尚未充分涵盖的机制之一。由于人类和兔眼炎症机制存在主要的物种差异,最相关的试验系统是人类眼睛本身。当前的研究聚焦于评估人角膜上皮细胞在常规眼刺激测试中的实际可用性。用人角膜上皮细胞培养物评估脂多糖对IL-1β释放的影响。研究结果表明,补体系统(通常存在于眼泪中)的存在可增强细胞因子的释放。然而,发现角膜细胞对补体系统具有高度抗性,这可归因于角膜上皮中发现的一种强大的补体调节蛋白CD59的高表达。据估计,组织库中废弃的角膜可为通过该方法进行的常规测试提供足够的材料。